Metabolism-driven Interactions Of Non-typeable Haemophilus Influenzae And Its Host: A Critical Factor In Infection?
Funder
National Health and Medical Research Council
Funding Amount
$474,932.00
Summary
Non-typeable Haemophilus influenzae (NTHi) is the underlying cause of many severe acute and chronic respiratory infections, which represent a significant burden to the healthcare system. As NTHi is unable to survive outside the human host, it is is highly adapted to survival in the body niches it colonizes. We are investigating how NTHI is able to survive in the presence of tissue inflammation, and whether it contributes to the inflammatory process through some of its metabolic products.
Impact Of Phasevarions Of Non-typeable Haemophilus Influenzae On Otitis Media Pathobiology And Vaccine Development.
Funder
National Health and Medical Research Council
Funding Amount
$613,124.00
Summary
Otitis media (OM), or middle ear infection, is a prevalent pediatric disease worldwide. Haemophilus influenzae causes 40% of acute OM cases, and most chronic OM and recurrent OM. There is a urgent need for vaccines to prevent OM. Our discovery of a novel genetic switch gives new insights into OM and the change from asymptomatic colonization to OM. The role of this switch on virulence in several dominant strains, and the impact on current and future candidates will be studied.
Evaluation Of Haemophilus Haemolyticus As A Preventative Therapy For NTHi Disease
Funder
National Health and Medical Research Council
Funding Amount
$445,659.00
Summary
Middle ear infections are the most common reason for a child to be given antibiotics and undergo surgery. This project will investigate whether a harmless bacterium found in the respiratory tract of children can be used as a probiotic to prevent bacterial ear infections. Benefits from reducing ear infections include fewer children undergoing surgery, fewer GP visits and antibiotic prescriptions, less time off work for parents, reduced hearing loss in children, and improved educational outcomes.
A Multi-centre, Double-blind, Randomised Controlled Trial To Evaluate The Efficacy Of 10 Valent-pneumococcal-Protein D Conjugate Vaccine In Reducing Respiratory Exacerbations In Children Aged ? 18 Months With Suppurative Lung Disease
Funder
National Health and Medical Research Council
Funding Amount
$1,160,660.00
Summary
Chronic suppurative (ie infected) lung diseases in children are major causes of poor health and deaths worldwide. Repeated childhood infections contribute to poor lung health in adults. The most common organism causing infection is non-typeable Haemophilus influenzae (NTHi). This study aims to determine whether a vaccine against NTHi can reduce repeated respiratory infections in children. If so, vaccination may lead to substantial improvements in current/ future lung health, and considerable dir ....Chronic suppurative (ie infected) lung diseases in children are major causes of poor health and deaths worldwide. Repeated childhood infections contribute to poor lung health in adults. The most common organism causing infection is non-typeable Haemophilus influenzae (NTHi). This study aims to determine whether a vaccine against NTHi can reduce repeated respiratory infections in children. If so, vaccination may lead to substantial improvements in current/ future lung health, and considerable direct and indirect cost of disease savings.Read moreRead less